Hetero Launches Patient Compliant Pack Of Favivir 800/200 For COVID-19 Treatment

Hetero, one of India’s leading generic pharmaceutical companies and the world’s largest producer of antiretroviral drugs, announces the launch of first-ever ‘Patient Compliant Pack’ of Favivir 800/200 for the treatment of mild-to-moderate symptomatic COVID-19 patients in India.Favivir 800/200 will be available in a patient-friendly pack containing 16 tablets of favipiravir 800mg & 2 tablets of favipiravir 200mg, which is priced at Rs. 2,640/-.The higher strength of favipiravir 800 mg from Hetero has been approved by the Drug Controller General of India (DCGI). The product will be marketed and distributed by Hetero Healthcare Limited.The launch of ‘Favivir 800/200’ is aimed at enhancing patients’ adherence to treatment regimen by reducing the number of pills they are required to consume per day. The initial regimen of favipiravir 200mg requires patients to consume a total of 122 tablets for the 14-day treatment course.However, with the new Favivir 800/200 pack, the pill intake number is reduced to 32 tablets, effectively cutting down the pill burden by nearly 75%, leading to better treatment outcomes.Favivir is the second drug developed by Hetero after Covifor (remdesivir) used in the treatment of Covid-19. It is an oral antiviral medication that has shown positive clinical outcomes. The product will be made available at all retail medical outlets and hospital pharmacies across the country and sold only on prescription.Favivir has been the most prescribed brand in the market, as per IPM July 2020.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!